| # | Title | Journal | Year | Citations |
|---|
| 1 | A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance | BMJ, The | 2021 | 1,567 |
| 2 | SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness | Lancet, The | 2021 | 882 |
| 3 | Mitigating the wider health effects of covid-19 pandemic response | BMJ, The | 2020 | 723 |
| 4 | Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study | Lancet, The | 2021 | 479 |
| 5 | SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway | Nature Microbiology | 2022 | 352 |
| 6 | Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank | BMC Medicine | 2020 | 307 |
| 7 | Risk of hospital admission with coronavirus disease 2019 in healthcare workers and their households: nationwide linkage cohort study | BMJ, The | 2020 | 261 |
| 8 | Community transmission of monkeypox in the United Kingdom, April to May 2022 | Eurosurveillance | 2022 | 245 |
| 9 | First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland | Nature Medicine | 2021 | 205 |
| 10 | Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design | Lancet Infectious Diseases, The | 2022 | 202 |
| 11 | Framework for the development and evaluation of complex interventions: gap analysis, workshop and consultation-informed update | Health Technology Assessment | 2021 | 184 |
| 12 | SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland | Nature Medicine | 2022 | 182 |
| 13 | Epidemiology of Seasonal Coronaviruses: Establishing the Context for the Emergence of Coronavirus Disease 2019 | Journal of Infectious Diseases | 2020 | 176 |
| 14 | Excess all-cause mortality during the COVID-19 pandemic in Europe – preliminary pooled estimates from the EuroMOMO network, March to April 2020 | Eurosurveillance | 2020 | 174 |
| 15 | Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial | Lancet, The | 2022 | 161 |
| 16 | Effect of Vaccination on Transmission of SARS-CoV-2 | New England Journal of Medicine | 2021 | 150 |
| 17 | COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study | Lancet Respiratory Medicine,the | 2021 | 119 |
| 18 | Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil | Lancet, The | 2022 | 109 |
| 19 | Investigation into cases of hepatitis of unknown aetiology among young children, Scotland, 1 January 2022 to 12 April 2022 | Eurosurveillance | 2022 | 96 |
| 20 | BNT162b2 and ChAdOx1 nCoV-19 Vaccine Effectiveness against Death from the Delta Variant | New England Journal of Medicine | 2021 | 89 |
| 21 | Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into Scotland | Nature Microbiology | 2021 | 88 |
| 22 | Estimated number of deaths directly averted in people 60 years and older as a result of COVID-19 vaccination in the WHO European Region, December 2020 to November 2021 | Eurosurveillance | 2021 | 87 |
| 23 | COVID-19 – exploring the implications of long-term condition type and extent of multimorbidity on years of life lost: a modelling study | Wellcome Open Research | 2020 | 85 |
| 24 | Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil | Nature Medicine | 2022 | 85 |
| 25 | Impact of COVID-19 on accident and emergency attendances and emergency and planned hospital admissions in Scotland: an interrupted time-series analysis | Journal of the Royal Society of Medicine | 2020 | 82 |
| 26 | Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 (PIMS-TS): Prospective, national surveillance, United Kingdom and Ireland, 2020 | Lancet Regional Health - Europe, The | 2021 | 73 |
| 27 | Impact of COVID-19 lockdown on emergency asthma admissions and deaths: national interrupted time series analyses for Scotland and Wales | Thorax | 2021 | 70 |
| 28 | Effectiveness of First Dose of COVID-19 Vaccines Against Hospital Admissions in Scotland: National Prospective Cohort Study of 5.4 Million People | SSRN Electronic Journal | 0 | 66 |
| 29 | A large multi-country outbreak of monkeypox across 41 countries in the WHO European Region, 7 March to 23 August 2022 | Eurosurveillance | 2022 | 62 |
| 30 | Rapid Epidemiological Analysis of Comorbidities and Treatments as risk factors for COVID-19 in Scotland (REACT-SCOT): A population-based case-control study | PLoS Medicine | 2020 | 61 |
| 31 | Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II): protocol for an observational study using linked Scottish national data | BMJ Open | 2020 | 59 |
| 32 | Real-time monitoring shows substantial excess all-cause mortality during second wave of COVID-19 in Europe, October to December 2020 | Eurosurveillance | 2021 | 53 |
| 33 | Adeno-associated virus 2 infection in children with non-A–E hepatitis | Nature | 2023 | 51 |
| 34 | Influence of socioeconomic deprivation on interventions and outcomes for patients admitted with COVID-19 to critical care units in Scotland: A national cohort study | Lancet Regional Health - Europe, The | 2021 | 49 |
| 35 | Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications | Expert Review of Pharmacoeconomics and Outcomes Research | 2021 | 48 |
| 36 | Burden of Disease Methods: A Guide to Calculate COVID-19 Disability-Adjusted Life Years | International Journal of Public Health | 2021 | 47 |
| 37 | The future of zoonotic risk prediction | Philosophical Transactions of the Royal Society B: Biological Sciences | 2021 | 47 |
| 38 | COVID-19 – exploring the implications of long-term condition type and extent of multimorbidity on years of life lost: a modelling study | Wellcome Open Research | 2020 | 46 |
| 39 | Impact of healthcare-associated infection on length of stay | Journal of Hospital Infection | 2021 | 46 |
| 40 | Outbreak of sexually transmitted, extensively drug-resistant Shigella sonnei in the UK, 2021–22: a descriptive epidemiological study | Lancet Infectious Diseases, The | 2022 | 46 |
| 41 | Population vulnerability to COVID-19 in Europe: a burden of disease analysis | Archives of Public Health | 2020 | 45 |
| 42 | Impact of COVID-19 lockdown on the incidence and mortality of acute exacerbations of chronic obstructive pulmonary disease: national interrupted time series analyses for Scotland and Wales | BMC Medicine | 2021 | 45 |
| 43 | Impact of the COVID-19 pandemic on community antibiotic prescribing in Scotland | JAC-Antimicrobial Resistance | 2020 | 44 |
| 44 | Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): an International Cancer Benchmarking Partnership (ICBP) population-based study | Lancet Oncology, The | 2022 | 42 |
| 45 | Relation of severe COVID-19 to polypharmacy and prescribing of psychotropic drugs: the REACT-SCOT case-control study | BMC Medicine | 2021 | 41 |
| 46 | Valuing the years of life lost due to COVID-19: the differences and pitfalls | International Journal of Public Health | 2020 | 39 |
| 47 | Population-level effectiveness of a national HIV preexposure prophylaxis programme in MSM | Aids | 2021 | 38 |
| 48 | Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021 | Eurosurveillance | 2021 | 38 |
| 49 | The Impact of Vaccination on Incidence and Outcomes of SARS-CoV-2 Infection in Patients with Kidney Failure in Scotland | Journal of the American Society of Nephrology: JASN | 2022 | 38 |
| 50 | First dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and cerebral venous sinus thrombosis: A pooled self-controlled case series study of 11.6 million individuals in England, Scotland, and Wales | PLoS Medicine | 2022 | 37 |
